Eric Schadt, a serial entrepreneur and expert in computational biology, is leaving his post as Chief Scientist at Pathos AI ...

Johnson & Johnson has secured another approval for its multiple myeloma drug Tecvayli (teclistamab), with the European ...

Kinvard Bio is one of the few companies seriously trying to change that. It started as a scientific spinout from the Andrew ...

US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of commissioner ...

Anthropic's Claude Science performed impressively in a protein design exercise, designing binders against 14 out of 15 ...

England is one of a handful of countries globally to have already exceeded the WHO benchmark of treating 80% of all known ...

But Sohonos has not lived up to its sales potential, despite being the only drug on the market, perhaps owing to relatively ...

More than 20,000 biotechnology leaders gathered in San Diego for the 2026 BIO International Convention under the theme, ...

The Advanced Research Projects Agency for Health (ARPA-H) has awarded Siemens Healthineers up to $31.1 million over five years to accelerate the development of autonomous, remote, endovascular ...

Join Amiculum for an exclusive live webinar and audience Q&A to gain practical insights from global payer research and ...

AC Immune SA, a clinical-stage biopharmaceutical company developing targeted therapeutics for neurodegenerative diseases, has announced positive interim results from a Phase 1 study of ACI-19764 – its ...

Hong Kong biopharma company Akeso has secured clinical trial clearance in China for a next-generation antibody-drug conjugate ...